ACADIA Pharmaceuticals Inc.

Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe!

Y! ACAD analyst ratings Berkstump2's ACAD TA Chart Clive Ballard on Pimavanserin for severe ADP Acadia Important Dates Longusa - Peak Sales Projections #ACAD @ Stocktwits $ACAD stream @ Twitter ACAD @ BioPharmaCatalyst.com

ACAD / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
17159	DXCM vs ACAD	GN	jim_pd		2	10/28/2020 1:07:15 PM

17158	Re: Peak Sales Est - after CTAD DRP Data Pres	GN	Biotech2050		2	10/28/2020 12:36:57 PM

17157	Acadia Earnings History and Estimate for the 3rd Quarter	GN	Paul777333		7	10/27/2020 10:49:43 PM

17156	Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) Conference	GN	sphericalkutz		2	10/27/2020 1:42:47 PM

17155	Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) Conference	GN	Biotech2050		12	10/27/2020 11:39:06 AM

17154	Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) Conference	GN	JBird61		8	10/27/2020 11:13:53 AM

17153	Re: Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) Conference	GN	sphericalkutz		2	10/27/2020 10:53:14 AM

17151	Hopefully the price may try to close gap around 52 with favorable news eom	GN	jim_pd		2	10/27/2020 9:56:19 AM

17150	Re: Market down 650 points, 2.35% (S&P -1.86%)	GN	sphericalkutz		1	10/26/2020 8:08:07 PM

17149	After hours and options	GN	inouknow		1	10/26/2020 7:48:38 PM

BOARDS Sign In for Filters